{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:17:53Z","timestamp":1761128273026,"version":"3.32.0"},"reference-count":19,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"published-print":{"date-parts":[[1998,1]]},"abstract":"<jats:p>Experimental murine L. major infection is characterized by the expansion of distinct CD4+ T cell subsets. The Th1 response is related to production of IFN-&lt;FONT FACE=\"Symbol\"&gt;g&lt;\/font&gt; and resolution of infection, whereas Th-2 response with production of IL-4 and IL-10 and dissemination of infection. The objective of this study was to measure the circulating levels of IFN-&lt;FONT FACE=\"Symbol\"&gt;g&lt;\/font&gt;, IL-10 and TNF-&lt;FONT FACE=\"Symbol\"&gt;a&lt;\/font&gt; in patients with visceral leishmaniasis (VL) before, during and at the end of therapy and to examine the association between cytokine levels and activity of VL. Fifteen patients with VL were evaluated. The cytokine determinations were done by using the enzyme-linked immunoassay (ELISA) before, during and at the end of therapy. At baseline, we detected circulating levels of IFN-&lt;FONT FACE=\"Symbol\"&gt;g&lt;\/font&gt; in 13 of 15 patients (median = 60 pg\/ml); IL-10 in 14 of 15 patients (median = 141.4 pg\/ml); and TNF-&lt;FONT FACE=\"Symbol\"&gt;a&lt;\/font&gt; in 13 of 14 patients (median = 38.9 pg\/ml). As patients improved, following antimonial therapy, circulating levels of IL-10 showed an exponential decay (y = 82.34 e\u20130,10367x, r = \u20130.659; p &lt; 0.001). IFN-&lt;FONT FACE=\"Symbol\"&gt;g&lt;\/font&gt; was no longer detected after 7\/14 days of therapy. On the other hand, circulating levels of TNF-&lt;FONT FACE=\"Symbol\"&gt;a&lt;\/font&gt; had a less pronounced decay with time on therapy, remaining detectable in most patients during the first seven days of therapy (y = 36.99-0.933x, r = \u20130.31; p = 0.05). Part of the expression of a successful response to therapy may, therefore, include reduction in secretion of inflammatory as well as suppressive cytokines. Since IL-10 and IFN-&lt;FONT FACE=\"Symbol\"&gt;g&lt;\/font&gt; are both detected prior to therapy, the recognized cellular immune depression seen in these patients may be due to biological predominance of IL-10 (type 2 cytokine), rather than lack of IFN-&lt;FONT FACE=\"Symbol\"&gt;g &lt;\/font&gt;(type 1 cytokine) production.<\/jats:p>","DOI":"10.1590\/s0036-46651998000100007","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T13:24:54Z","timestamp":1114608294000},"page":"31-34","source":"Crossref","is-referenced-by-count":34,"title":["Presence of Circulating Levels of Interferon-&lt;FONT FACE=Symbol&gt;g&lt;\/font&gt;, Interleukin-10 and Tumor Necrosis Factor-&lt;FONT FACE=Symbol&gt;a&lt;\/font&gt; in Patients with Visceral Leishmaniasis"],"prefix":"10.1590","volume":"40","author":[{"given":"Iara Marques de","family":"MEDEIROS","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo; Universidade Federal do Rio Grande do Norte"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adauto","family":"CASTELO","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinaldo","family":"SALOM\u00c3O","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/infdis\/163.4.853","article-title":"Tumor necrosis factor (Cachectin) in human visceral leishmaniasis","volume":"163","author":"BARRAL-NETO M.","year":"1991","journal-title":"J. infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1172\/JCI112209","article-title":"Absence of gamma-interferon and interleukin-production during active visceral leishmaniasis","volume":"76","author":"CARVALHO E. M.","year":"1985","journal-title":"J. clin. Invest.","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9738","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.152.12.5949","article-title":"Restoration of IFN-<FONT FACE=\"Symbol\">g<\/font> production and lymphocyte proliferation in visceral leishmaniasis","volume":"152","author":"CARVALHO E. M.","year":"1994","journal-title":"J. Immunol.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4049\/jimmunol.150.2.353","article-title":"Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production","volume":"150","author":"DEL PRETE G.","year":"1993","journal-title":"J. Immunol.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1172\/JCI116570","article-title":"Interleukin 10 production correlates with pathology in human Leishmania donovani infections","volume":"92","author":"GHALIB H. W.","year":"1993","journal-title":"J. clin. Invest.","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9738","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.169.1.59","article-title":"Reciprocal expression of interferon-gamma or interleukin 4 during the resolution or progression of murine leishmaniasis: Evidence for expansion of distinct helper T cell subsets","volume":"169","author":"HEINZEL . P.","year":"1989","journal-title":"J. exp. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1007","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/infdis\/165.6.1094","article-title":"Diminished in vitro production of interleukin-1 and tumor necrosis factor-<FONT FACE=\"Symbol\">a<\/font> during acute visceral Leishmaniasis and recovery after therapy","volume":"165","author":"HO J. L.","year":"1992","journal-title":"J. infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1172\/JCI116878","article-title":"Potencial role for interleukin-10 in the immunosupression associated with Kala-azar","volume":"92","author":"HOLADAY B. J.","year":"1993","journal-title":"J. clin. Invest.","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9738","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI116372","article-title":"In vitro cytokine profiles in patients with kala-azar: marked elevation of both interleukin-10 and interferon-gamma","volume":"91","author":"KARP C. L.","year":"1993","journal-title":"J. clin. Invest.","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9738","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/172.6.1573","article-title":"Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response","volume":"172","author":"LILES W. C.","year":"1995","journal-title":"J. infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60449-6","article-title":"Properties and functions of interleukin-10","volume":"56","author":"MOSMANN T. R.","year":"1994","journal-title":"Advanc. Immunol.","ISSN":"https:\/\/id.crossref.org\/issn\/0065-2776","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.4049\/jimmunol.138.7.2290","article-title":"Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction and response to treatment with interleukin 2 and interferon-gamma","volume":"138","author":"MURRAY H. W.","year":"1987","journal-title":"J. Immunol.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"},{"key":"ref13","series-title":"Principles and pratice of infectious diseases","first-page":"2066","volume-title":"Leishmania species: visceral (kala-azar), cutaneous and mucosal leishmaniasis.","author":"PEARSON R. D.","year":"1990","edition":"3"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/infdis\/161.5.988","article-title":"Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis","volume":"161","author":"PISA P.","year":"1990","journal-title":"J. infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/eji.1830231147","article-title":"Interleukin 4 and interleukin 10 synergize to inhibit cell-mediated immunity in vivo","volume":"23","author":"POWRIE F.","year":"1993","journal-title":"Europ. J. Immunol.","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2980","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S0036-46651996000200005","article-title":"Plasma levels of tumor necrosis factor-<FONT FACE=\"Symbol\">a<\/font> in patients with visceral leishmaniasis (kala-azar).: Association with activity of the disease and clinical remission following antimonial therapy","volume":"38","author":"SALOM\u00c3O R.","year":"1996","journal-title":"Rev. Inst. Med. trop. S. Paulo","ISSN":"https:\/\/id.crossref.org\/issn\/0036-4665","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1084\/jem.181.4.1527","article-title":"A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells express a Th1-type cytokine profile and to produce interleukin 12","volume":"181","author":"SKEIKY Y. A. W.","year":"1995","journal-title":"J. exp. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1007","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1084\/jem.170.6.2097","article-title":"Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis","volume":"170","author":"TITUS R. G.","year":"1989","journal-title":"J. exp. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1007","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4049\/jimmunol.153.2.768","article-title":"Role and effect of TNF-<FONT FACE=\"Symbol\">a<\/font> in experimental visceral leishmaniasis","volume":"153","author":"TUMANG M. C. T.","year":"1994","journal-title":"J. Immunol.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v40n1\/08-98.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T22:38:49Z","timestamp":1735684729000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46651998000100007&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["S0036-46651998000100007"],"URL":"https:\/\/doi.org\/10.1590\/s0036-46651998000100007","relation":{},"ISSN":["0036-4665"],"issn-type":[{"type":"electronic","value":"0036-4665"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}